We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.8M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$5.97M
3
EPAM icon
EPAM Systems
EPAM
+$3.35M
4
O icon
Realty Income
O
+$1.92M
5
KRG icon
Kite Realty
KRG
+$1.67M

Top Sells

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$18.3M
2
AAPL icon
Apple
AAPL
+$13.9M
3
MSFT icon
Microsoft
MSFT
+$9.44M
4
AMZN icon
Amazon
AMZN
+$5.45M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$5.29M

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 12.47%
3 Healthcare 12.1%
4 Financials 11.43%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
2801
DELISTED
Esperion Therapeutics
ESPR
– –
-7,777
Closed -$93.7K
GLUE icon
2802
Monte Rosa Therapeutics
GLUE
$1.37B
– –
-3,598
Closed -$80.2K
GWRS icon
2803
Global Water Resources
GWRS
$236M
– –
-3,396
Closed -$63.6K
IBIO icon
2804
iBio
IBIO
$73M
– –
-126
Closed -$66.7K
IMRX icon
2805
Immuneering
IMRX
$335M
– –
-2,814
Closed -$74.7K
INNV icon
2806
InnovAge Holding
INNV
$1.46B
– –
-6,479
Closed -$42.8K
IPSC icon
2807
Century Therapeutics
IPSC
$366M
– –
-3,737
Closed -$94K
TBHC
2808
DELISTED
The Brand House Collective
TBHC
– –
-3,926
Closed -$75.4K
KODK icon
2809
Kodak
KODK
$992M
– –
-4,410
Closed -$30K
LYEL icon
2810
Lyell Immunopharma
LYEL
$341M
– –
-390
Closed -$116K
RJET
2811
Republic Airways Holdings
RJET
$964M
– –
-631
Closed -$72.5K
MLCO icon
2812
Melco Resorts & Entertainment
MLCO
$2.17B
– –
-8,700
Closed -$89.1K
MTRX icon
2813
Matrix Service
MTRX
$330M
– –
-7,156
Closed -$74.9K
NGNE icon
2814
Neurogene
NGNE
$729M
– –
-235
Closed -$34K
NKTX icon
2815
Nkarta
NKTX
$170M
– –
-3,933
Closed -$109K
PAVM icon
2816
PAVmed
PAVM
$32.4M
– –
-31
Closed -$119K
PLSE icon
2817
Pulse Biosciences
PLSE
$3.28B
– –
-3,991
Closed -$86.2K
PRLD icon
2818
Prelude Therapeutics
PRLD
$452M
– –
-3,194
Closed -$99.8K
REKR icon
2819
Rekor Systems
REKR
$102M
– –
-8,598
Closed -$98.8K
RFL icon
2820
Rafael Holdings
RFL
$110M
– –
-3,079
Closed -$93.3K
SB icon
2821
Safe Bulkers
SB
$768M
– –
-17,034
Closed -$88.1K
SCOR icon
2822
Comscore
SCOR
$90.4M
– –
-957
Closed -$74.7K
SGHT icon
2823
Sight Sciences
SGHT
$462M
– –
-3,584
Closed -$81.4K
SKYT
2824
DELISTED
SkyWater Technology
SKYT
– –
-2,708
Closed -$73.7K
SPRY icon
2825
ARS Pharmaceuticals
SPRY
$587M
– –
-6,383
Closed -$63.7K
111 112
113
114 115

Similar funds

GWM
Graybill Wealth Management Elmhurst, Illinois $328M AUM 21.42% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
AFS
Aft Forsyth & Sober Valrico, Florida $328M AUM 25.24% 1-Year Est. Return
BAM
Blueshift Asset Management Red Bank, New Jersey $330M AUM 7.9% 1-Year Est. Return
ML
Maniro Ltd Nassau $330M AUM
ISFAN
Investor's Fiduciary Advisor Network Snoqualmie, Washington $326M AUM 19.7% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
ECH
ER Collective Holdings Washington, District of Columbia $326M AUM

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.